Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma
A Phase II Study of Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma
Sponsor: Brigham and Women's Hospital
A PHASE2 clinical study on Nasopharyngeal Carcinoma, this trial is completed. The trial is conducted by Brigham and Women's Hospital and has accumulated 9 data snapshots since 2006. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Nov 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Nov 2021 [monthly]
Completed PHASE2
-
Sep 2019 — Jan 2021 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
▶ Show 4 earlier versions
-
Oct 2018 — Sep 2019 [monthly]
Active Not Recruiting PHASE2
-
Jun 2018 — Oct 2018 [monthly]
Active Not Recruiting PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE2
First recorded
Oct 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Brigham and Women's Hospital
- Dana-Farber Cancer Institute
- Massachusetts General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .